Seeking Alpha

Verenium +57% premarket after BASF buyout offer

  • Industrial biotech company Verenium (VRNM) +57.7% premarket after agreeing to be acquired by BASF (BASFY.PK) for ~$51.2M, or $4/share, a 59% premium to Thursday's closing price.
  • VRNM focuses on developing and selling high-performance enzymes used in food and fuel markets.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector